| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |